- Home
- KMDA vs RWAY Comparison
KMDA vs RWAY Comparison
Compare KMDA & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- RWAY
- Stock Information
- Founded
- KMDA 1990
- RWAY 2015
- Country
- KMDA Israel
- RWAY United States
- Employees
- KMDA N/A
- RWAY N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- RWAY
- Sector
- KMDA Health Care
- RWAY
- Exchange
- KMDA Nasdaq
- RWAY Nasdaq
- Market Cap
- KMDA 443.4M
- RWAY 410.4M
- IPO Year
- KMDA N/A
- RWAY 2021
- Fundamental
- Price
- KMDA $7.72
- RWAY $11.05
- Analyst Decision
- KMDA Strong Buy
- RWAY Buy
- Analyst Count
- KMDA 2
- RWAY 5
- Target Price
- KMDA $13.00
- RWAY $10.80
- AVG Volume (30 Days)
- KMDA 55.4K
- RWAY 352.6K
- Earning Date
- KMDA 08-13-2025
- RWAY 08-07-2025
- Dividend Yield
- KMDA 2.59%
- RWAY 12.85%
- EPS Growth
- KMDA 31.21
- RWAY 51.80
- EPS
- KMDA 0.28
- RWAY 1.67
- Revenue
- KMDA $167,235,000.00
- RWAY $140,021,000.00
- Revenue This Year
- KMDA $14.51
- RWAY N/A
- Revenue Next Year
- KMDA $9.31
- RWAY N/A
- P/E Ratio
- KMDA $28.31
- RWAY $6.64
- Revenue Growth
- KMDA 11.83
- RWAY N/A
- 52 Week Low
- KMDA $5.08
- RWAY $8.35
- 52 Week High
- KMDA $9.16
- RWAY $12.09
- Technical
- Relative Strength Index (RSI)
- KMDA 53.97
- RWAY 58.97
- Support Level
- KMDA $7.64
- RWAY $10.96
- Resistance Level
- KMDA $7.91
- RWAY $11.27
- Average True Range (ATR)
- KMDA 0.18
- RWAY 0.20
- MACD
- KMDA -0.02
- RWAY -0.03
- Stochastic Oscillator
- KMDA 50.00
- RWAY 46.62
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.